Related Experiment Video

Updated: Aug 23, 2025

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.4K

Coronary Artery Disease in Patients Undergoing Transvalvular Aortic Valve Implantation

Yinghao Lim1, Kent Anthony Tan1, Ivandito Kuntjoro1

  • 1Department of Cardiology, National University Heart Centre Singapore.

Interventional Cardiology (London, England)
|October 28, 2022
PubMed

Insights

Managing coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI) is crucial. This review guides optimal pre- and post-procedure care for improved patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery disease (CAD) frequently coexists with severe aortic stenosis.
  • Transcatheter aortic valve implantation (TAVI) is a growing treatment option, increasing the need for managing CAD in these patients.
  • Younger patients undergoing TAVI have a higher likelihood of requiring future coronary access.

Purpose of the Study:

  • To review the challenges of managing CAD in patients undergoing TAVI.
  • To provide guidance on optimizing pre- and post-procedural coronary access.
  • To discuss strategies for avoiding coronary obstruction during TAVI.

Main Methods:

  • Review of current literature and evidence.
  • Analysis of pre-procedural assessment and revascularization strategies.
  • Discussion of procedural planning and post-procedural access optimization.

Main Results:

  • TAVI has revolutionized CAD management in severe aortic stenosis.
  • Careful planning is essential to prevent coronary obstruction during TAVI.
  • Optimizing coronary access post-TAVI is critical for long-term management.

Conclusions:

  • Integrated management of CAD and aortic stenosis is vital for TAVI candidates.
  • Future research should focus on long-term outcomes of CAD management in TAVI patients.
  • Multidisciplinary collaboration is key to optimizing patient care.

Keywords:
Transcatheter aortic valve interventionaortic stenosisaortic valvecardiac catheterisationcoronary artery disease

More Related Videos

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation06:59

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Published on: June 3, 2018

10.7K
Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.4K

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
25
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
46
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
26
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16